Global Uncertainty Is Impacting Deal-Making, Investment Decisions

Deloitte Economist Considers How Macroeconomic Issues Affect Biotech

Deloitte chief global economist Ira Kalish said in a Biocom webinar that the war in Ukraine increased existing macroeconomic uncertainty, which is keeping businesses and investors from deploying capital.

Global economy, finance, forex, financial markets news background
The war in Ukraine has increased economic uncertainty globally • Source: Alamy

The biotechnology industry, and health care overall, is generally somewhat protected from broader economic concerns, but the war in Ukraine adds to an existing sense of uncertainty due to rising inflation, ongoing labor shortages and continued supply constraints that were already troubling investors who have moved money out of the industry, Deloitte chief global economist Ira Kalish said in a recent fireside chat hosted by Biocom California.

"A month ago, before the Russian invasion of Ukraine, I would have told you that the biggest issues facing us...

More from Deals

More from Business

IPO Update: With Just Two Small Offerings In Q2, What’s Next?

 
• By 

With low valuations for biopharma companies that recently went public and little hope of a near-term turnaround as uncertainty lingers, IPO numbers may stay low for the rest of 2025.

Actuate Is Looking For A Buyer To Advance Pancreatic Cancer Candidate

 

After presenting encouraging Phase II data on the GSK-3 inhibitor elraglusib at ASCO, Actuate Therapeutics is hoping to hold a pre-NDA meeting with the US FDA.

Novartis Upbeat Even With Entresto Expiry Looming

 
• By 

Swiss major confident that new oncology drugs will fill revenue gap.